drugset / Trial / NCT02305355

Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia

NCT02305355

Phase 4 Completed 68 enrolled Kuhnil Pharmaceutical Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

Assess efficacy and safety of Omacor® 4g with statin treatment for lowering TG levels in subjects with type 2 Diabetes combined with hyperlipidemia

Timeline

Start
2009-02
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3-acids ethylesters 90 Unknown 4 g
Background Atorvastatin Small molecule
Background Pravastatin Small molecule
Background Rosuvastatin Small molecule
Background Simvastatin Small molecule